Read more

September 20, 2021
1 min read
Save

‘An important down payment’: US pledges $2B to fight antimicrobial resistance

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

The Infectious Diseases Society of America said it was “encouraged” by a Biden administration plan to allocate more than $2 billion in federal funding to build infrastructure to combat drug-resistant infections.

On Friday, the administration announced that it would allocate the large sum from the American Rescue Plan to support infection prevention and efforts to combat antimicrobial resistance, according to the IDSA.

Press release.

“This investment serves as an important down payment to build the necessary infrastructure to effectively combat drug-resistant infections,” the IDSA said in a statement.

According to the IDSA, $385 million of the allocated funds will go toward strengthening antimicrobials resistance infrastructure, including expanding antibiotic resistance laboratory testing — giving every state the ability to screen for resistant pathogens — supporting a stewardship leader in each state to work with health care facilities on improving antibiotic use, and increasing the number of health care facilities that report antibiotic use and resistance data to the CDC’s National Healthcare Safety Network.

“While extremely promising, this funding was provided on a one-time basis from emergency supplemental funds approved by Congress earlier this year,” the IDSA said. “This approach effectively creates a funding cliff that will halt these activities if sustainable annual funding is not provided.”